A detailed history of Van Cleef Asset Management,Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Van Cleef Asset Management,Inc holds 5,790 shares of ABT stock, worth $667,587. This represents 0.08% of its overall portfolio holdings.

Number of Shares
5,790
Previous 5,790 -0.0%
Holding current value
$667,587
Previous $601,000 9.82%
% of portfolio
0.08%
Previous 0.08%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $10,952 - $12,096
-100 Reduced 1.7%
5,790 $658,000
Q4 2023

Feb 02, 2024

SELL
$90.19 - $110.4 $9,920 - $12,144
-110 Reduced 1.83%
5,890 $648,000
Q3 2023

Nov 07, 2023

SELL
$95.53 - $114.62 $72,984 - $87,569
-764 Reduced 11.3%
6,000 $581,000
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $74,073 - $82,533
-735 Reduced 9.8%
6,764 $737,000
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $96 - $114
1 Added 0.01%
7,499 $759,000
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $16,730 - $19,627
176 Added 2.4%
7,498 $823,000
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $102 - $123
1 Added 0.01%
7,322 $796,000
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $114,020 - $139,040
-1,000 Reduced 12.02%
7,321 $867,000
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $73,823 - $90,392
-639 Reduced 7.13%
8,321 $1.17 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $13,117 - $15,441
-124 Reduced 1.37%
8,960 $1.04 Million
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $21,768 - $25,645
-200 Reduced 2.15%
9,084 $1.09 Million
Q4 2020

Feb 17, 2021

BUY
$105.0 - $114.42 $13,545 - $14,760
129 Added 1.41%
9,284 $1.02 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $108,593 - $131,878
-1,185 Reduced 11.46%
9,155 $996,000
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $149,825 - $219,086
-2,385 Reduced 18.74%
10,340 $816,000
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $6,138 - $6,655
-75 Reduced 0.59%
12,725 $1.07 Million
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $62,246 - $75,256
940 Added 7.93%
12,800 $1.02 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $20,979 - $23,766
320 Added 2.77%
11,860 $858,000
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $43,783 - $52,819
-720 Reduced 5.87%
11,540 $847,000
Q2 2018

Aug 10, 2018

SELL
$57.57 - $63.54 $2,302 - $2,541
-40 Reduced 0.33%
12,260 $748,000
Q1 2018

May 04, 2018

SELL
$56.27 - $63.62 $1,969 - $2,226
-35 Reduced 0.28%
12,300 $737,000
Q4 2017

Feb 02, 2018

SELL
$53.68 - $57.47 $14,762 - $15,804
-275 Reduced 2.18%
12,335 $704,000
Q3 2017

Oct 27, 2017

BUY
$48.06 - $53.64 $606,036 - $676,400
12,610
12,610 $673,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Van Cleef Asset Management,Inc Portfolio

Follow Van Cleef Asset Management,Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Cleef Asset Management,Inc, based on Form 13F filings with the SEC.

News

Stay updated on Van Cleef Asset Management,Inc with notifications on news.